NCT01382797 - ALK37-005: A Study of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC) | Biotech Hunter

Enrollment

157

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions

Opioid-induced Constipation

Interventions

DRUG

ALKS 37

Capsules for oral administration

DRUG

Placebo

Capsules for oral administration

Trial Locations (20)

11218

Alkermes Study Site, Brooklyn

30281

Alkermes Study Site, Stockbridge

32174

Alkermes Study Site, Ormond Beach

32724

Alkermes Investigational Site, DeLand

33709

Alkermes Study Site, St. Petersburg

45224

Alkermes Study Site, Cincinnati

49009

Alkermes Study Site, Kalamazoo

70114

Alkermes Study Site, New Orleans

73134

Alkermes Study Site, Oklahoma City

78228

Alkermes Study Site, San Antonio

80211

Alkermes Study Site, Denver

83704

Alkermes Study Site, Boise

85053

Alkermes Study Site, Phoenix

85206

Alkermes Study Site, Mesa

89144

Alkermes Study Site, Las Vegas

91105

Alkermes Study Site, Pasadena

91950

Alkermes Study Site, National City

92056

Alkermes Study Site, Oceanside

97504

Alkermes Study Site, Medford

07823

Alkermes Study Site, Belvidere